Sinovac Biotech Ltd. (NYSE Amex: SVA) has received a revised Drug Supplementary Application Approval for Panflu, Sinovac's pandemic influenza vaccine ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE